跳至主要内容
临床试验/ACTRN12622000075785
ACTRN12622000075785尚未招募未知

EUS-guided portal pressure measurement in assessing the effectiveness of suboptimal beta-blocker dosing for primary variceal prophylaxis in patients with cirrhosis

Royal Adelaide Hospital0 个研究点目标入组 30 人开始时间: 2022年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1 - Ability to give informed consent
  • 2 - Patient with Child A or B cirrhosis - on suboptimal doses of a beta-blocker for variceal primary prophylaxis:
  • (i) HR > 55bpm
  • (ii) Propranolol dose < 320mg daily but >= 80mg daily or Carvedilol < 12.5mg daily but >= 6.25mg daily

排除标准

  • 1 - Ischaemic heart disease or congestive cardiac failure
  • 2 - Concurrent diagnosis of hepatocellular cancer
  • 3 - Pregnant or breastfeeding women
  • 4 - Creatinine clearance <60 mL/min
  • 5 - Those whom investigators believe are unlikely to have more than 12 month’s life expectancy

研究者

相似试验

Endoscopic ultrasound (EUS)-guided portal pressure... | 临床试验